+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Animal Parvovirus Vaccine Market - Global Forecast 2026-2032- Product Image
Animal Parvovirus Vaccine Market - Global Forecast 2026-2032- Product Image
Sale

Animal Parvovirus Vaccine Market - Global Forecast 2026-2032

  • Report

  • 196 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6133159
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Animal Parvovirus Vaccine Market is projected to reach USD 6.21 Billion in 2026. It is expected to continue growing at a CAGR of 7.68%, reaching USD 9.67 Billion by 2032.

Animal Parvovirus Vaccines: Executive Summary

Animal parvovirus vaccines support prevention of clinically significant viral disease in companion animals, livestock, and other susceptible populations. Their use is shaped by vaccination protocols, veterinary access, animal ownership patterns, biosecurity practices, regulatory requirements, and the ability to maintain product quality across storage and distribution. Market conditions therefore vary by species, geography, disease surveillance capacity, and the maturity of veterinary healthcare systems.

Prevention Is Shifting Toward Integrated Disease Management

The landscape is moving from routine product administration toward integrated prevention programs that combine vaccination, diagnostics, epidemiological surveillance, herd or kennel management, sanitation, and owner education. Veterinary professionals increasingly emphasize age-appropriate schedules, maternal-antibody considerations, booster compliance, and risk-based protocols. Cold-chain reliability, traceability, counterfeit prevention, and responsible antimicrobial stewardship also influence adoption and confidence in vaccination programs.

Artificial Intelligence Strengthens Surveillance and Vaccination Decisions

Artificial intelligence can improve animal parvovirus control by identifying patterns in clinical records, laboratory results, vaccination histories, and geographic disease reports. Predictive analytics may help veterinarians prioritize high-risk populations, detect unusual outbreaks, and refine reminder systems for overdue vaccinations. Computer vision and automated record processing can support triage and documentation, while generative tools may improve client education. These applications require representative datasets, veterinary validation, privacy safeguards, and careful management of false positives and model bias.

Regional Insights: Uneven Veterinary Access Shapes Prevention

North America generally benefits from established companion-animal vaccination practices, laboratory capacity, and structured veterinary delivery, although access and compliance differ between urban and rural communities. Latin America combines expanding companion-animal care with variable public-health infrastructure, import conditions, and cold-chain consistency. Europe is influenced by coordinated animal-health frameworks, strong veterinary networks, and differing national protocols. The Middle East faces varied climatic, logistical, and regulatory conditions, while Africa’s priorities include affordability, rural access, surveillance, and livestock-protection capacity. Asia-Pacific presents wide contrasts between highly developed veterinary systems and rapidly expanding markets where workforce, distribution, and awareness remain uneven.

Group Insights: Policy and Economic Blocs Have Distinct Priorities

ASEAN countries are shaped by cross-border animal movement, differing regulatory systems, and the need to strengthen regional surveillance and veterinary access. BRICS members span diverse livestock, companion-animal, manufacturing, and public-sector capabilities, making harmonization and local availability important considerations. The European Union emphasizes coordinated animal-health rules, traceability, and evidence-based veterinary practice. G7 economies typically have mature clinical infrastructure and advanced pharmacovigilance expectations. GCC states place emphasis on import controls, specialized veterinary services, and protection of valuable companion and livestock populations. NATO members may benefit from established emergency-planning and biosecurity capabilities, although animal-health policy remains nationally administered.

Country Insights: National Systems Determine Adoption Conditions

Australia combines strong veterinary standards with geographic dispersion and biosecurity sensitivity. Brazil has substantial livestock and companion-animal needs alongside regional differences in access. Canada’s large geography makes distribution and rural veterinary coverage important. China and India require approaches suited to diverse production systems, urbanization, and varying veterinary capacity. France, Germany, Italy, and Spain operate within European regulatory and animal-health frameworks while retaining national practice differences. Japan and South Korea have advanced veterinary services and high expectations for product quality and traceability. Mexico faces heterogeneous access and cross-border animal-movement considerations. Russia’s large territory and climate variation make logistics and surveillance significant. The United Kingdom emphasizes regulated veterinary practice, documentation, and biosecurity. The United States combines broad veterinary infrastructure with varied regional access, animal-owner compliance, and disease-reporting practices.

Priorities for Leaders: Improve Access, Evidence, and Trust

Industry leaders should segment prevention strategies by species, age, production setting, and local disease risk rather than rely on uniform protocols. They should strengthen cold-chain monitoring, batch traceability, post-vaccination surveillance, and field feedback loops while supporting veterinarians with practical education and digital adherence tools. Partnerships with diagnostic laboratories, veterinary associations, public authorities, shelters, farms, and animal-owner organizations can improve coverage and outbreak responsiveness. Leaders should also validate AI applications prospectively, document model limitations, and maintain human clinical oversight. Clear evidence communication, transparent safety monitoring, and locally appropriate pricing and distribution practices are essential for durable confidence.

Methodology: Structured Synthesis of Veterinary and Market Evidence

This executive summary uses a structured qualitative approach focused on the animal parvovirus vaccine domain. It considers disease-prevention principles, veterinary delivery conditions, regulatory and biosecurity factors, regional variation, economic-group characteristics, and country-level healthcare infrastructure. Insights are framed as evidence-based drivers and constraints rather than numerical market claims. Interpretation should be supplemented with current peer-reviewed studies, official animal-health surveillance, regulatory documents, vaccination guidelines, laboratory data, and field assessments for product-specific or jurisdiction-specific decisions.

Conclusion: Resilient Prevention Depends on Coordinated Systems

Animal parvovirus vaccine outcomes depend on more than vaccine availability. Effective prevention requires reliable veterinary access, appropriate schedules, quality-assured supply chains, disease surveillance, biosecurity, informed animal owners, and responsive public and private-sector coordination. Regional and national differences make localized implementation essential. Organizations that combine validated science with practical delivery, transparent safety monitoring, and responsible digital innovation will be better positioned to strengthen protection across companion-animal and production-animal settings.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Animal Parvovirus Vaccine Market, by Animal Type
7.1. Introduction
7.2. Canine
7.3. Feline
7.4. Porcine
7.4.1. Adult
7.4.2. Piglet
8. Animal Parvovirus Vaccine Market, by Vaccine Type
8.1. Introduction
8.2. Inactivated
8.3. Live Attenuated
8.4. Recombinant
9. Animal Parvovirus Vaccine Market, by Product Format
9.1. Introduction
9.2. Liquid
9.3. Lyophilized
10. Animal Parvovirus Vaccine Market, by Distribution Channel
10.1. Introduction
10.2. Offline
10.3. Online
11. Animal Parvovirus Vaccine Market, by End User
11.1. Introduction
11.2. Animal Farm
11.3. Veterinary Clinic
11.4. Veterinary Hospital
12. Animal Parvovirus Vaccine Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Animal Parvovirus Vaccine Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Animal Parvovirus Vaccine Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Boehringer Ingelheim International GmbH
16.2. Ceva Santé Animale
16.3. Dechra Pharmaceuticals PLC
16.4. Elanco Animal Health Incorporated
16.5. HIPRA, S.A.
16.6. Merck & Co., Inc.
16.7. Phibro Animal Health Corporation
16.8. Vaxxinova GmbH
16.9. Vetoquinol S.A.
16.10. Virbac S.A.
16.11. Zoetis Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Animal Parvovirus Vaccine Market, Years Considered for the Study
FIGURE 2. Global Animal Parvovirus Vaccine Market, Research Design
FIGURE 3. Global Animal Parvovirus Vaccine Market, Research Framework
FIGURE 4. Global Animal Parvovirus Vaccine Market, Data Triangulation
FIGURE 5. Global Animal Parvovirus Vaccine Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Animal Parvovirus Vaccine Market Size, by Animal Type, 2025 vs 2032 (%)
FIGURE 7. Global Animal Parvovirus Vaccine Market Size, by Animal Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Animal Parvovirus Vaccine Market Size, by Vaccine Type, 2025 vs 2032 (%)
FIGURE 9. Global Animal Parvovirus Vaccine Market Size, by Vaccine Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Animal Parvovirus Vaccine Market Size, by Product Format, 2025 vs 2032 (%)
FIGURE 11. Global Animal Parvovirus Vaccine Market Size, by Product Format, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Animal Parvovirus Vaccine Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Animal Parvovirus Vaccine Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Animal Parvovirus Vaccine Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Animal Parvovirus Vaccine Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Animal Parvovirus Vaccine Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Animal Parvovirus Vaccine Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Animal Parvovirus Vaccine Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Animal Parvovirus Vaccine Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Animal Parvovirus Vaccine Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Animal Parvovirus Vaccine Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Animal Parvovirus Vaccine Market Segmentation & Coverage
TABLE 2. Global Animal Parvovirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 3. Global Animal Parvovirus Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 4. Global Canine Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Canine Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Canine Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Feline Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Feline Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Feline Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Porcine Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Porcine Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Porcine Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Adult Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Adult Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Adult Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Piglet Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Piglet Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Piglet Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Animal Parvovirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 20. Global Inactivated Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Inactivated Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Inactivated Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Live Attenuated Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Live Attenuated Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Live Attenuated Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Recombinant Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Recombinant Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Recombinant Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Animal Parvovirus Vaccine Market Size, by Product Format, 2017-2032 (USD Million)
TABLE 30. Global Liquid Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Liquid Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Liquid Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Lyophilized Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Lyophilized Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Lyophilized Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Animal Parvovirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 37. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Animal Parvovirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 44. Global Animal Farm Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Animal Farm Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Animal Farm Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Veterinary Clinic Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Veterinary Clinic Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Veterinary Clinic Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Veterinary Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Veterinary Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Veterinary Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Animal Parvovirus Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Asia-Pacific Animal Parvovirus Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Asia-Pacific Animal Parvovirus Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 56. Asia-Pacific Animal Parvovirus Vaccine Market Size, by Porcine, 2017-2032 (USD Million)
TABLE 57. Asia-Pacific Animal Parvovirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 58. Asia-Pacific Animal Parvovirus Vaccine Market Size, by Product Format, 2017-2032 (USD Million)
TABLE 59. Asia-Pacific Animal Parvovirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 60. Asia-Pacific Animal Parvovirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 61. North America Animal Parvovirus Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. North America Animal Parvovirus Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 63. North America Animal Parvovirus Vaccine Market Size, by Porcine, 2017-2032 (USD Million)
TABLE 64. North America Animal Parvovirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 65. North America Animal Parvovirus Vaccine Market Size, by Product Format, 2017-2032 (USD Million)
TABLE 66. North America Animal Parvovirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 67. North America Animal Parvovirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 68. Latin America Animal Parvovirus Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Latin America Animal Parvovirus Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 70. Latin America Animal Parvovirus Vaccine Market Size, by Porcine, 2017-2032 (USD Million)
TABLE 71. Latin America Animal Parvovirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 72. Latin America Animal Parvovirus Vaccine Market Size, by Product Format, 2017-2032 (USD Million)
TABLE 73. Latin America Animal Parvovirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 74. Latin America Animal Parvovirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 75. Europe Animal Parvovirus Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Europe Animal Parvovirus Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 77. Europe Animal Parvovirus Vaccine Market Size, by Porcine, 2017-2032 (USD Million)
TABLE 78. Europe Animal Parvovirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 79. Europe Animal Parvovirus Vaccine Market Size, by Product Format, 2017-2032 (USD Million)
TABLE 80. Europe Animal Parvovirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 81. Europe Animal Parvovirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 82. Middle East Animal Parvovirus Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Middle East Animal Parvovirus Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 84. Middle East Animal Parvovirus Vaccine Market Size, by Porcine, 2017-2032 (USD Million)
TABLE 85. Middle East Animal Parvovirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 86. Middle East Animal Parvovirus Vaccine Market Size, by Product Format, 2017-2032 (USD Million)
TABLE 87. Middle East Animal Parvovirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 88. Middle East Animal Parvovirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 89. Africa Animal Parvovirus Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Africa Animal Parvovirus Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 91. Africa Animal Parvovirus Vaccine Market Size, by Porcine, 2017-2032 (USD Million)
TABLE 92. Africa Animal Parvovirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 93. Africa Animal Parvovirus Vaccine Market Size, by Product Format, 2017-2032 (USD Million)
TABLE 94. Africa Animal Parvovirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 95. Africa Animal Parvovirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 96. Global Animal Parvovirus Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. ASEAN Animal Parvovirus Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. ASEAN Animal Parvovirus Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 99. ASEAN Animal Parvovirus Vaccine Market Size, by Porcine, 2017-2032 (USD Million)
TABLE 100. ASEAN Animal Parvovirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 101. ASEAN Animal Parvovirus Vaccine Market Size, by Product Format, 2017-2032 (USD Million)
TABLE 102. ASEAN Animal Parvovirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 103. ASEAN Animal Parvovirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 104. GCC Animal Parvovirus Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. GCC Animal Parvovirus Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 106. GCC Animal Parvovirus Vaccine Market Size, by Porcine, 2017-2032 (USD Million)
TABLE 107. GCC Animal Parvovirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 108. GCC Animal Parvovirus Vaccine Market Size, by Product Format, 2017-2032 (USD Million)
TABLE 109. GCC Animal Parvovirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 110. GCC Animal Parvovirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 111. European Union Animal Parvovirus Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. European Union Animal Parvovirus Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 113. European Union Animal Parvovirus Vaccine Market Size, by Porcine, 2017-2032 (USD Million)
TABLE 114. European Union Animal Parvovirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 115. European Union Animal Parvovirus Vaccine Market Size, by Product Format, 2017-2032 (USD Million)
TABLE 116. European Union Animal Parvovirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 117. European Union Animal Parvovirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 118. BRICS Animal Parvovirus Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. BRICS Animal Parvovirus Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 120. BRICS Animal Parvovirus Vaccine Market Size, by Porcine, 2017-2032 (USD Million)
TABLE 121. BRICS Animal Parvovirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 122. BRICS Animal Parvovirus Vaccine Market Size, by Product Format, 2017-2032 (USD Million)
TABLE 123. BRICS Animal Parvovirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 124. BRICS Animal Parvovirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 125. G7 Animal Parvovirus Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. G7 Animal Parvovirus Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 127. G7 Animal Parvovirus Vaccine Market Size, by Porcine, 2017-2032 (USD Million)
TABLE 128. G7 Animal Parvovirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 129. G7 Animal Parvovirus Vaccine Market Size, by Product Format, 2017-2032 (USD Million)
TABLE 130. G7 Animal Parvovirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 131. G7 Animal Parvovirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 132. NATO Animal Parvovirus Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. NATO Animal Parvovirus Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 134. NATO Animal Parvovirus Vaccine Market Size, by Porcine, 2017-2032 (USD Million)
TABLE 135. NATO Animal Parvovirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 136. NATO Animal Parvovirus Vaccine Market Size, by Product Format, 2017-2032 (USD Million)
TABLE 137. NATO Animal Parvovirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 138. NATO Animal Parvovirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 139. Global Animal Parvovirus Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 140. United States Animal Parvovirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 141. United States Animal Parvovirus Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 142. United States Animal Parvovirus Vaccine Market Size, by Porcine, 2017-2032 (USD Million)
TABLE 143. United States Animal Parvovirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 144. United States Animal Parvovirus Vaccine Market Size, by Product Format, 2017-2032 (USD Million)
TABLE 145. United States Animal Parvovirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 146. United States Animal Parvovirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 147. Canada Animal Parvovirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 148. Canada Animal Parvovirus Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 149. Canada Animal Parvovirus Vaccine Market Size, by Porcine, 2017-2032 (USD Million)
TABLE 150. Canada Animal Parvovirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 151. Canada Animal Parvovirus Vaccine Market Size, by Product Format, 2017-2032 (USD Million)
TABLE 152. Canada Animal Parvovirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 153. Canada Animal Parvovirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 154. Mexico Animal Parvovirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 155. Mexico Animal Parvovirus Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 156. Mexico Animal Parvovirus Vaccine Market Size, by Porcine, 2017-2032 (USD Million)
TABLE 157. Mexico Animal Parvovirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 158. Mexico Animal Parvovirus Vaccine Market Size, by Product Format, 2017-2032 (USD Million)
TABLE 159. Mexico Animal Parvovirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 160. Mexico Animal Parvovirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. Brazil Animal Parvovirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 162. Brazil Animal Parvovirus Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 163. Brazil Animal Parvovirus Vaccine Market Size, by Porcine, 2017-2032 (USD Million)
TABLE 164. Brazil Animal Parvovirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 165. Brazil Animal Parvovirus Vaccine Market Size, by Product Format, 2017-2032 (USD Million)
TABLE 166. Brazil Animal Parvovirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 167. Brazil Animal Parvovirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 168. United Kingdom Animal Parvovirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 169. United Kingdom Animal Parvovirus Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 170. United Kingdom Animal Parvovirus Vaccine Market Size, by Porcine, 2017-2032 (USD Million)
TABLE 171. United Kingdom Animal Parvovirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 172. United Kingdom Animal Parvovirus Vaccine Market Size, by Product Format, 2017-2032 (USD Million)
TABLE 173. United Kingdom Animal Parvovirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 174. United Kingdom Animal Parvovirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. Germany Animal Parvovirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 176. Germany Animal Parvovirus Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 177. Germany Animal Parvovirus Vaccine Market Size, by Porcine, 2017-2032 (USD Million)
TABLE 178. Germany Animal Parvovirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 179. Germany Animal Parvovirus Vaccine Market Size, by Product Format, 2017-2032 (USD Million)
TABLE 180. Germany Animal Parvovirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 181. Germany Animal Parvovirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 182. France Animal Parvovirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 183. France Animal Parvovirus Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 184. France Animal Parvovirus Vaccine Market Size, by Porcine, 2017-2032 (USD Million)
TABLE 185. France Animal Parvovirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 186. France Animal Parvovirus Vaccine Market Size, by Product Format, 2017-2032 (USD Million)
TABLE 187. France Animal Parvovirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 188. France Animal Parvovirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 189. Russia Animal Parvovirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 190. Russia Animal Parvovirus Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 191. Russia Animal Parvovirus Vaccine Market Size, by Porcine, 2017-2032 (USD Million)
TABLE 192. Russia Animal Parvovirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 193. Russia Animal Parvovirus Vaccine Market Size, by Product Format, 2017-2032 (USD Million)
TABLE 194. Russia Animal Parvovirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 195. Russia Animal Parvovirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 196. Italy Animal Parvovirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 197. Italy Animal Parvovirus Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 198. Italy Animal Parvovirus Vaccine Market Size, by Porcine, 2017-2032 (USD Million)
TABLE 199. Italy Animal Parvovirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 200. Italy Animal Parvovirus Vaccine Market Size, by Product Format, 2017-2032 (USD Million)
TABLE 201. Italy Animal Parvovirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 202. Italy Animal Parvovirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 203. Spain Animal Parvovirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 204. Spain Animal Parvovirus Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 205. Spain Animal Parvovirus Vaccine Market Size, by Porcine, 2017-2032 (USD Million)
TABLE 206. Spain Animal Parvovirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 207. Spain Animal Parvovirus Vaccine Market Size, by Product Format, 2017-2032 (USD Million)
TABLE 208. Spain Animal Parvovirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 209. Spain Animal Parvovirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 210. China Animal Parvovirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 211. China Animal Parvovirus Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 212. China Animal Parvovirus Vaccine Market Size, by Porcine, 2017-2032 (USD Million)
TABLE 213. China Animal Parvovirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 214. China Animal Parvovirus Vaccine Market Size, by Product Format, 2017-2032 (USD Million)
TABLE 215. China Animal Parvovirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 216. China Animal Parvovirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 217. India Animal Parvovirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 218. India Animal Parvovirus Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 219. India Animal Parvovirus Vaccine Market Size, by Porcine, 2017-2032 (USD Million)
TABLE 220. India Animal Parvovirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 221. India Animal Parvovirus Vaccine Market Size, by Product Format, 2017-2032 (USD Million)
TABLE 222. India Animal Parvovirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 223. India Animal Parvovirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 224. Japan Animal Parvovirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 225. Japan Animal Parvovirus Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 226. Japan Animal Parvovirus Vaccine Market Size, by Porcine, 2017-2032 (USD Million)
TABLE 227. Japan Animal Parvovirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 228. Japan Animal Parvovirus Vaccine Market Size, by Product Format, 2017-2032 (USD Million)
TABLE 229. Japan Animal Parvovirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 230. Japan Animal Parvovirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 231. Australia Animal Parvovirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 232. Australia Animal Parvovirus Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 233. Australia Animal Parvovirus Vaccine Market Size, by Porcine, 2017-2032 (USD Million)
TABLE 234. Australia Animal Parvovirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 235. Australia Animal Parvovirus Vaccine Market Size, by Product Format, 2017-2032 (USD Million)
TABLE 236. Australia Animal Parvovirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 237. Australia Animal Parvovirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 238. South Korea Animal Parvovirus Vaccine Market Size, 2017-2032 (USD Million)
TABLE 239. South Korea Animal Parvovirus Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 240. South Korea Animal Parvovirus Vaccine Market Size, by Porcine, 2017-2032 (USD Million)
TABLE 241. South Korea Animal Parvovirus Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 242. South Korea Animal Parvovirus Vaccine Market Size, by Product Format, 2017-2032 (USD Million)
TABLE 243. South Korea Animal Parvovirus Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 244. South Korea Animal Parvovirus Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 245. Global Animal Parvovirus Vaccine Market Share, by Key Player, 2025
TABLE 246. Global Animal Parvovirus Vaccine Market, Key Experts

Companies Mentioned

  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • HIPRA, S.A.
  • Merck & Co., Inc.
  • Phibro Animal Health Corporation
  • Vaxxinova GmbH
  • Vetoquinol S.A.
  • Virbac S.A.
  • Zoetis Inc.

Related Topics

Related Reports

Inactivated Porcine Parvovirus Vaccine Market - Global Forecast 2026-2032 - Product Image

Inactivated Porcine Parvovirus Vaccine Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Veterinary/Animal Vaccines Market - Global Forecast 2026-2032 - Product Image

Veterinary/Animal Vaccines Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Veterinary Vaccines - Global Strategic Business Report - Product Image

Veterinary Vaccines - Global Strategic Business Report

  • Report
  • 277 Pages
  • Global
From
Swine Vaccines - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Swine Vaccines - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 120 Pages
  • Global
From
Dog Vaccine - Global Strategic Business Report - Product Image

Dog Vaccine - Global Strategic Business Report

  • Report
  • 576 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.